Home Performance of a fully automated quantitative neopterin measurement assay in a routine voluntary blood donation setting
Article
Licensed
Unlicensed Requires Authentication

Performance of a fully automated quantitative neopterin measurement assay in a routine voluntary blood donation setting

  • Peter Mayersbach , Dietmar Fuchs and Harald Schennach
Published/Copyright: December 18, 2009

Abstract

Background: Acute virus infections are indicated by increased serum neopterin concentrations. Testing of blood donations for increased neopterin was introduced in the Austrian Tyrol in 1986 and throughout Austria in 1994 to improve the safety of blood transfusions. Radioimmunoassay (RIA) was the first available test, and the 98th percentile for neopterin concentrations from 76,500 donations was defined as the cut-off threshold, excluding donations with neopterin ≥10 nmol/L. When ELISAs were introduced on fully automated test systems to measure neopterin concentrations, results were generally higher and the cut-off was adjusted up to 12 nmol/L.

Methods: In early 2006, new equipment (Hamilton Microlab Star® pipettor+Dade Behring ELISA Processor III, BEP III®) became available which monitors sample and reagent volumes for each uptake and dispense, and takes the viscosity of the fluids into account. Using this system, the performance of neopterin determinations was evaluated over 21 months and compared to earlier data.

Results: When the new apparatuses were introduced, an immediate decrease in mean neopterin concentrations and the percentage of samples with neopterin concentrations ≥10 nmol/L was observed. The 55,516 measurements performed in 2007 showed a mean value of 5.5 nmol/L. Neopterin in 680 donations (1.23%) were ≥10 nmol/L.

Conclusions: The new Hamilton diluter increased the accuracy of the neopterin test procedure. Results are now identical with those of RIA and ELISA when run in a semi-automated manner. Differences in pipetting performance of standards and samples are considered as one possible explanation for the earlier discrepancies seen with the automated apparatus.

Clin Chem Lab Med 2010;48:373–7.


Corresponding author: Prim. Doz. Dr. Harald Schennach, Central Institute of Blood Transfusion and Immunology, University Hospital Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria Phone: +43 50504 22930, Fax: +43 50504 22934,

Received: 2009-9-18
Accepted: 2009-11-5
Published Online: 2009-12-18
Published in Print: 2010-03-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. Standardization of assays for clinically important enzymes that have high biologic variation: what is all the fuss about?
  3. Minireview
  4. Standardization in clinical enzymology: a challenge for the theory of metrological traceability
  5. Review
  6. Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?
  7. Opinion Paper
  8. The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for “normal” results
  9. Genetics and Molecular Diagnostics
  10. Integrated PCR amplification and detection processes on a Lab-on-Chip platform: a new advanced solution for molecular diagnostics
  11. Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility
  12. Association of the CD28/CTLA4/ICOS polymorphisms with susceptibility to rheumatoid arthritis
  13. Lack of association between DAZ gene methylation patterns and spermatogenic failure
  14. General Clinical Chemistry and Laboratory Medicine
  15. Evaluation of five routine glucose methods on an Olympus AU5400 analyzer using the CDC hexokinase reference method
  16. Multicentre evaluation of the Tosoh HbA1c G8 analyser
  17. Performance of a fully automated quantitative neopterin measurement assay in a routine voluntary blood donation setting
  18. Assay of oxidized fibrinogen reactivity (OFR) as a biomarker of oxidative stress in human plasma: the role of lysine analogs
  19. Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome
  20. Development and validation of a high performance liquid chromatography method to determine linezolid concentrations in pig pulmonary tissue
  21. Is heparin plasma suitable for the determination of B-type natriuretic peptide on the Beckman-Coulter Access 2?
  22. Composition of kidney stone fragments obtained after extracorporeal shock wave lithotripsy
  23. Reference Values and Biological Variations
  24. Gender does not influence cystatin C concentrations in healthy volunteers
  25. Stability of serum thyroid hormones following 8–11 years of cold storage
  26. Infectious Diseases
  27. Detection and quantitation of Epstein-Barr virus (EBV) DNA in EDTA whole blood samples using automated sample preparation and real time PCR
  28. Letters to the Editor
  29. The polymorphisms –1131T>C and the S19W of the APOA5 gene are not associated with coronary artery disease in a Brazilian population
  30. Tissue factor +5466A>G and –1208D>I genetic polymorphisms and severity of rheumatoid arthritis
  31. Ability of deferasirox to bind iron during measurement of iron
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.072/html?lang=en
Scroll to top button